• Glucose, Random, Blood
  • Complement Component C3, Nephritic Factor
  • Bilirubin Total, Body Fluid
  • Islet Cell (IA-2) Autoantibodies
  • 5-Hydroxyindoleacetic Acid (5-HIAA), Urine
  • Cancer Antigen (CA) 19-9, Peritoneal Fluid
  • Phospholipid (Cardiolipin) Antibody, IgM
  • Lamotrigine, Serum
  • Biopsy, Thymus
  • Antinuclear Antibody (ANA), IFA Patterning
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
Medical Test

Reference Ranges
Access to Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis is restricted.